Literature DB >> 26172429

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Seema Jain1, Wesley H Self, Richard G Wunderink, Sherene Fakhran, Robert Balk, Anna M Bramley, Carrie Reed, Carlos G Grijalva, Evan J Anderson, D Mark Courtney, James D Chappell, Chao Qi, Eric M Hart, Frank Carroll, Christopher Trabue, Helen K Donnelly, Derek J Williams, Yuwei Zhu, Sandra R Arnold, Krow Ampofo, Grant W Waterer, Min Levine, Stephen Lindstrom, Jonas M Winchell, Jacqueline M Katz, Dean Erdman, Eileen Schneider, Lauri A Hicks, Jonathan A McCullers, Andrew T Pavia, Kathryn M Edwards, Lyn Finelli.   

Abstract

BACKGROUND: Community-acquired pneumonia is a leading infectious cause of hospitalization and death among U.S. adults. Incidence estimates of pneumonia confirmed radiographically and with the use of current laboratory diagnostic tests are needed.
METHODS: We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among adults 18 years of age or older in five hospitals in Chicago and Nashville. Patients with recent hospitalization or severe immunosuppression were excluded. Blood, urine, and respiratory specimens were systematically collected for culture, serologic testing, antigen detection, and molecular diagnostic testing. Study radiologists independently reviewed chest radiographs. We calculated population-based incidence rates of community-acquired pneumonia requiring hospitalization according to age and pathogen.
RESULTS: From January 2010 through June 2012, we enrolled 2488 of 3634 eligible adults (68%). Among 2320 adults with radiographic evidence of pneumonia (93%), the median age of the patients was 57 years (interquartile range, 46 to 71); 498 patients (21%) required intensive care, and 52 (2%) died. Among 2259 patients who had radiographic evidence of pneumonia and specimens available for both bacterial and viral testing, a pathogen was detected in 853 (38%): one or more viruses in 530 (23%), bacteria in 247 (11%), bacterial and viral pathogens in 59 (3%), and a fungal or mycobacterial pathogen in 17 (1%). The most common pathogens were human rhinovirus (in 9% of patients), influenza virus (in 6%), and Streptococcus pneumoniae (in 5%). The annual incidence of pneumonia was 24.8 cases (95% confidence interval, 23.5 to 26.1) per 10,000 adults, with the highest rates among adults 65 to 79 years of age (63.0 cases per 10,000 adults) and those 80 years of age or older (164.3 cases per 10,000 adults). For each pathogen, the incidence increased with age.
CONCLUSIONS: The incidence of community-acquired pneumonia requiring hospitalization was highest among the oldest adults. Despite current diagnostic tests, no pathogen was detected in the majority of patients. Respiratory viruses were detected more frequently than bacteria. (Funded by the Influenza Division of the National Center for Immunizations and Respiratory Diseases.).

Entities:  

Mesh:

Year:  2015        PMID: 26172429      PMCID: PMC4728150          DOI: 10.1056/NEJMoa1500245

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  48 in total

1.  Diagnosis of Legionella infection.

Authors:  David R Murdoch
Journal:  Clin Infect Dis       Date:  2002-12-12       Impact factor: 9.079

2.  Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia.

Authors:  D R Murdoch; R T Laing; G D Mills; N C Karalus; G I Town; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79.

Authors:  A P Kendal; T R Cate
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

Authors:  Patrick G P Charles; Michael Whitby; Andrew J Fuller; Robert Stirling; Alistair A Wright; Tony M Korman; Peter W Holmes; Keryn J Christiansen; Grant W Waterer; Robert J P Pierce; Barrie C Mayall; John G Armstrong; Michael G Catton; Graeme R Nimmo; Barbara Johnson; Michelle Hooy; M L Grayson
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

5.  Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy.

Authors:  H M Pollock; E L Hawkins; J R Bonner; T Sparkman; J B Bass
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

6.  Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test.

Authors:  A S Monto; H F Maassab
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

Review 7.  Medical microbiology: laboratory diagnosis of invasive pneumococcal disease.

Authors:  Anja M Werno; David R Murdoch
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

8.  Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander.

Authors:  Alicia M Fry; Xiaoyan Lu; Sonja J Olsen; Malinee Chittaganpitch; Pongpun Sawatwong; Somrak Chantra; Henry C Baggett; Dean Erdman
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

Review 9.  Multiplex PCR and emerging technologies for the detection of respiratory pathogens.

Authors:  Angela M Caliendo
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

10.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

View more
  693 in total

1.  Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.

Authors:  Daniel M Musher; Maria B Rodriguez-Barradas
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Is Pneumonia a Risk Factor or a Risk Marker for Long-Term Mortality?

Authors:  Carlos G Grijalva
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

3.  Unbiased Detection of Respiratory Viruses by Use of RNA Sequencing-Based Metagenomics: a Systematic Comparison to a Commercial PCR Panel.

Authors:  Erin H Graf; Keith E Simmon; Keith D Tardif; Weston Hymas; Steven Flygare; Karen Eilbeck; Mark Yandell; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

Review 4.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

5.  What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?

Authors:  A T Newall
Journal:  Hum Vaccin Immunother       Date:  2016-07-11       Impact factor: 3.452

Review 6.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

7.  Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.

Authors:  Giorgia Purcaro; Christiaan A Rees; Jeffrey A Melvin; Jennifer M Bomberger; Jane E Hill
Journal:  J Breath Res       Date:  2018-07-03       Impact factor: 3.262

8.  Legionella pneumonia complicated by rhabdomyolysis.

Authors:  Bayu Sutarjono; Janeah Alexis; Jency Cynthia Sachidanandam
Journal:  BMJ Case Rep       Date:  2019-06-20

9.  Trends in Incidence of Methicillin-resistant Staphylococcus aureus Bloodstream Infections Differ by Strain Type and Healthcare Exposure, United States, 2005-2013.

Authors:  Isaac See; Yi Mu; Valerie Albrecht; Maria Karlsson; Ghinwa Dumyati; Dwight J Hardy; Mackenzie Koeck; Ruth Lynfield; Joelle Nadle; Susan M Ray; William Schaffner; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

10.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.